What outcomes are important to patients with mild cognitive impairment or Alzheimer’s disease, their caregivers, and health-care professionals? A systematic review
<br><strong>Introduction: </strong>Clinical trials involving patients with Alzheimer’s disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease m...
Hlavní autoři: | Tochel, C, Smith, M, Baldwin, H, Gustavsson, A, Ly, A, Bexelius, C, Nelson, M, Bintener, C, Fantoni, E, Garre-Olmo, J, Janssen, O, Jindra, C, Jørgensen, IF, McKeown, A, Öztürk, B, Ponjoan, A, Potashman, MH, Reed, C, Roncancio-Diaz, E, Vos, S, Sudlow, C |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2019
|
Podobné jednotky
-
Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube
Autor: Janssen, O, a další
Vydáno: (2020) -
Conducting public involvement in dementia research: the contribution of the European Working Group of People with Dementia to the ROADMAP project
Autor: Diaz, A, a další
Vydáno: (2021) -
Health outcome prioritisation in Alzheimer’s disease: understanding the ethical landscape
Autor: McKeown, A, a další
Vydáno: (2020) -
Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol
Autor: Landeiro, F, a další
Vydáno: (2018) -
Good governance and multidimensional poverty: a comparative analysis of 71 countries
Autor: Jindra, C, a další
Vydáno: (2019)